Generate Biomedicines is a series c plus startup based in United States. 2 investors tracked.
Generate Biomedicines is a company founded in 2019 headquartered in the United States. Its most recent tracked round is Series-c-plus. Brouky records 4 investors associated with the company.
Generate Biomedicines is a biotherapeutics company developing a machine learning-based generative biology platform to create novel protein therapeutics.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.